Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: CSE: $FONE.C, OTC: $TRTC, CSE: $GLH.C, CSE: $HUGE.C, TSXV: $KHRN.V
Delta, Kelowna, BC - November 6, 2018 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today's edition of its series, Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: CSE: $FONE.C, OTC: $TRTC, CSE: $GLH.C, CSE: $HUGE.C, TSXV: $KHRN.V
Hear Investor ideas cannabis potcast on iTunes
Today's podcast overview/transcript:
From company news sources
Good afternoon and welcome to another Investorideas.com Potcast - following Cannabis news, stocks to watch as well as insights from thought leaders and experts.
Today we will be looking at announcements from Flower One Holdings Inc. trading on the CSE as FONE, Terra Tech Corp. trading on the OTC as TRTC, Golden Lead Holdings Ltd. trading on the OTC as GLDFF and the CSE as GLH, FSD Pharma Inc. trading on the CSE as HUGE and the OTCQB as FSDDF and Khiron Life Sciences Corp.trading on the TSX-Venture as KHRN and the OTCQB as KHRNF.
Flower One Holdings Inc., owner of Nevada's largest cannabis cultivation and production facility, announced that it will begin trading today in the United States on the OTCQB marketplace under the symbol "FLOOF".
"Today's listing on the OTCQB reaffirms our commitment to improving the Company's visibility and exposure in the United States," said Flower One's President and CEO, Ken Villazor. "We believe that trading on OTCQB will further broaden the Company's shareholder base by allowing prospective U.S.-based investors to more readily obtain information and access through a domestic trading platform. Flower One is sharply focused in the U.S. cannabis sector and this listing is vital to our overall growth strategy as a public company."
Home to the largest commercial scale greenhouse in the State of Nevada, Flower One aims to leverage the industry's leading agricultural technologies, utilizing innovative growing and sustainability practices to cultivate high-quality cannabis at scale for Nevada's growing cannabis market. The Company is licensed for medical marijuana cultivation and production, and recreational marijuana cultivation and production in the state of Nevada. Once canopied, targeted Q1 2019, the 455,000 square foot facility will be used for cannabis cultivation as well as the processing, production and high-volume packaging of dry flower, cannabis oils, concentrates and infused products.
Terra Tech Corp., a vertically integrated cannabis-focused agriculture company, announced that it signed a non-binding letter of intent to merge with Golden Leaf Holdings Ltd., a cannabis company with cultivation, production and retail operations built around recognized brands. Under the terms of the letter of intent, a wholly owned subsidiary of Terra Tech will amalgamate with Golden Leaf, with the resulting amalgamated corporation being a wholly owned subsidiary of Terra Tech. Consummation of the transaction is subject to a number of conditions, including entering into a mutually agreed definitive arrangement agreement, completion of due diligence, the waiting period for the Hart-Scott-Rodino Act, state and local regulatory approvals, approval by the Ontario courts, Terra Tech board approval, Golden Leaf receiving a positive fairness opinion, Canadian Securities Exchange (CSE) approval and Golden Leaf shareholder and board approval.
Peterson, CEO of Terra Tech, commented, "As new participants enter the cannabis industry the market is undergoing rapid consolidation. The companies that are vertically integrated with strong brands and multi-jurisdictional operations are best situated to achieve scale and retain market-leading positions. We are planning to merge with Golden Leaf's operations because its seed-to-sale business model is complementary to ours, encompassing both the Oregon and Canadian market which represent new markets for us, and touching Nevada where we are focused on gaining market share. Its 'Chalice Farms' retail dispensaries are well known and have an excellent reputation in Oregon, and the wholesale side of the business offers diverse, high quality cannabis products for all demographics, which are complementary to our existing wholesale product lines. This transaction, if completed, will create a combined company that will control 41 permits across cultivation, manufacturing, distribution and retail spanning Oregon, California and Nevada, in addition to 21 pending permit applications in multiple jurisdictions throughout the U.S."
Simpson, CEO of Golden Leaf, commented, "Golden Leaf is dedicated to building shareholder value and we are pleased to have this opportunity to combine forces with Terra Tech, an established, vertically-integrated cannabis operator with a presence in multiple states and, most importantly, a proven reputation and loyal customer base. We are excited at the prospect of significantly expanding our size and reach through this merger and believe that the combined company will improve our growth trajectory and enable us to benefit from several operational synergies that will improve the running of our business."
FSD Pharma Inc. announced today that its strategic R&D partner, SciCann Therapeutics Inc. received a positive International Search Authority (ISA) report from the Patent Cooperation Treaty (PCT) for its SCN-001 cannabidiol (CBD) combination therapy, the basis of its "Steady Stomach" product.
The comprehensive prior art search performed by ISA for the PCT/IL2018/051000 patent application by SciCann led the agency to conclude that the enhanced CBD combination therapy claimed by the patent application is novel and inventive.
Under the terms of FSD's strategic agreement with SciCann, FSD holds exclusive manufacturing and distribution rights for the "Steady Stomach" product in Canada.
Dr. Zohar Koren, Co-founder and CEO of SciCann stated, "This patent application covers the "Steady Stomach" product, for which we have recently launched the company's first clinical study with Irritable Bowel Syndrome (IBS) patients. The preliminary affirmation we received from the ISA regarding the novelty of this unique combination therapy is an important milestone, which allows us to file national phase applications in the US, Canada and the rest of the world in order to achieve comprehensive IP protection for the product. We believe that our strategy of developing novel and proprietary synergistic combination cannabinoid therapies is the right approach to bring new and IP protected products to the cannabinoid based pharmaceutical space."
Khiron Life Sciences Corp., an integrated medical cannabis company with its core operations in Colombia, announced in the news today that the Company has extended an agreement with Farmalisto, the regions leading digital drugstore, to market and distribute the Company's Kuida® CBD cosmeceutical brand to a population of over 120 million consumers in Mexico, subject to approvals from the Federal Commission for the Protection of Health Risks (COFEPRIS).
Kuida®, the first consumer brand of Khiron's Wellness unit, brings the benefits of cannabidol (CBD) to a comprehensive portfolio of skin and body care products for women. Launched in Colombia in September 2018 through retail, wholesale and online channels, Kuida® will now be available in Mexico, a significant market segment with a population of more than 120 Million. Mexico is among the top 10 markets in the world for cosmetics and personal care products (US Department of Commerce), and the second largest market for beauty products in Latin America.
Alvaro Torres, Khiron Co-founder and CEO stated, "Mexico is a priority market for Kuida®, where we see tremendous interest in new innovations in the beauty care market. As part of our previously announced business strategy to enter the Mexican market, extending our distribution deal with Farmalisto allows us to leverage their e-commerce capabilities and network to connect more women in Mexico with the Kuida® brand."
Farmalisto is one of Latin America's leading digital drugstores with more than one million monthly visits, sustained annual sales growth of 150%, and a strong presence in Mexico. Led by CEO and Co-founder Joaquin Mora, Farmalisto provides customers with innovative products, delivered with leading commercial technology, provided through the most innovative digital platform.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.
Subscribe to the new cannabis podcast series:
To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
Get the cannabis/hemp stock directory as an Investor ideas member, plus get weekly updates with new pot stocks added and get the daily potcast for Investor Ideas #Potcasts #Cannabis News and Stocks on the Move. Learn more https://www.investorideas.com/membership/
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts#Cannabis News and Stocks on the Move podcast and column and the Cleantech and Climate Change Podcast.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp. Learn more about Investor ideas podcast and news publication services and costs https://www.investorideas.com/News-Upload/
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
No comments:
Post a Comment